New trials show promise for immune checkpoint blockers in early-stage lung cancer

FHS
April 18, 2024
12:23 pm

A dendritic cell (DC) vaccine targeting patient-specific neoantigens to patients with resected non-small cell lung cancer (NSCLC).

Midi Health Raises $25M for Virtual Menopause Care Clinic – FemTech

Dr. Mindy Goldman (Chief Clinical Officer, Midi Health), Cindy Gentry, Sharon Meers (Co-Founder, Midi Health), Dr. Kathleen Jordan (Chief Medical Officer, Midi Health), Frédérique Dame

September 28, 2023

Arcturus Therapeutics extends cystic fibrosis treatment deal

Arcturus is advancing the mRNA therapeutic to treat cystic fibrosis. Credit: Magic mine/Shutterstock.com. Arcturus Therapeutics has extended an existing agreement with the Cystic Fibrosis (CF)

September 27, 2023

What Can Be Done for Severe RSV Cases in Adults?

Though there are now respiratory syncytial virus (RSV) vaccines approved by the FDA and recommended by the CDC for certain high-risk adults, what happens when

December 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.